Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cytokine Storm in COVID-19: “When You Come Out of the Storm, You Won’t Be the Same Person Who Walked in”
Vanessa Castelli, Annamaria Cimini, Claudio Ferri
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 120

Showing 1-25 of 120 citing articles:

Chemokines and chemokine receptors during COVID-19 infection
Bariaa Khalil, Noha Mousaad Elemam, Azzam A. Maghazachi
Computational and Structural Biotechnology Journal (2021) Vol. 19, pp. 976-988
Open Access | Times Cited: 209
JAK-STAT Pathway Inhibition and their Implications in COVID-19 Therapy
Sairaj Satarker, Antriya Annie Tom, Roshitha Ann Shaji, et al.
Postgraduate Medicine (2020) Vol. 133, Iss. 5, pp. 489-507
Open Access | Times Cited: 147
Oxidative Stress Status in COVID-19 Patients Hospitalized in Intensive Care Unit for Severe Pneumonia. A Pilot Study
Joël Pincemaïl, Étienne Cavalier, Corinne Charlier, et al.
Antioxidants (2021) Vol. 10, Iss. 2, pp. 257-257
Open Access | Times Cited: 120
Pro-Inflammatory and Anti-Inflammatory Interleukins in Infectious Diseases: A Comprehensive Review
Arwa A. Al-Qahtani, Fatimah S. Alhamlan, Ahmed A. Al‐Qahtani
Tropical Medicine and Infectious Disease (2024) Vol. 9, Iss. 1, pp. 13-13
Open Access | Times Cited: 69
Vitamin D: Evidence-Based Health Benefits and Recommendations for Population Guidelines
William B. Grant, Sunil J. Wimalawansa, Paweł Płudowski, et al.
Nutrients (2025) Vol. 17, Iss. 2, pp. 277-277
Open Access | Times Cited: 3
The impact of COVID-19 infection on the cytokine profile of pregnant women: A prospective case-control study
Atakan Tanaçan, Nuray Yazıhan, Seyit Ahmet Erol, et al.
Cytokine (2021) Vol. 140, pp. 155431-155431
Open Access | Times Cited: 80
Galectin-9, a Player in Cytokine Release Syndrome and a Surrogate Diagnostic Biomarker in SARS-CoV-2 Infection
Najmeh Bozorgmehr, Siavash Mashhouri, Eliana Perez Rosero, et al.
mBio (2021) Vol. 12, Iss. 3
Open Access | Times Cited: 75
Angiotensin-Converting-Enzyme 2 and Renin-Angiotensin System Inhibitors in COVID-19: An Update
Ashwin Kumar Shukla, Monisha Banerjee
High Blood Pressure & Cardiovascular Prevention (2021) Vol. 28, Iss. 2, pp. 129-139
Open Access | Times Cited: 66
Elucidating the Neuropathologic Mechanisms of SARS-CoV-2 Infection
Mar Pacheco‐Herrero, Luis O. Soto-Rojas, Charles R. Harrington, et al.
Frontiers in Neurology (2021) Vol. 12
Open Access | Times Cited: 60
Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of nsp15 endoribonuclease
Berta Canal, Ryo Fujisawa, Allison W. McClure, et al.
Biochemical Journal (2021) Vol. 478, Iss. 13, pp. 2465-2479
Open Access | Times Cited: 59
Glucocorticoids are double-edged sword in the treatment of COVID-19 and cancers
Ruixin Yang, Yingyan Yu
International Journal of Biological Sciences (2021) Vol. 17, Iss. 6, pp. 1530-1537
Open Access | Times Cited: 54
SARS-CoV-2: Targeted managements and vaccine development
Moiz Bakhiet, Sébastien Taurin
Cytokine & Growth Factor Reviews (2020) Vol. 58, pp. 16-29
Open Access | Times Cited: 58
Increased incidence of rhino‐orbital mucormycosis in an educational therapeutic hospital during the COVID‐19 pandemic in western Iran: An observational study
Manouchehr Avatef Fazeli, Leila Rezaei, Etrat Javadirad, et al.
Mycoses (2021) Vol. 64, Iss. 11, pp. 1366-1377
Open Access | Times Cited: 52
Hallmarks of immune response in COVID-19: Exploring dysregulation and exhaustion
Alessio Mazzoni, Lorenzo Salvati, Laura Maggi, et al.
Seminars in Immunology (2021) Vol. 55, pp. 101508-101508
Open Access | Times Cited: 52
An update review of globally reported SARS-CoV-2 vaccines in preclinical and clinical stages
Hamid Motamedi, Marzie Mahdizade Ari, Shirin Dashtbin, et al.
International Immunopharmacology (2021) Vol. 96, pp. 107763-107763
Open Access | Times Cited: 49
Coronavirus-Induced Host Cubic Membranes and Lipid-Related Antiviral Therapies: A Focus on Bioactive Plasmalogens
Yuru Deng, Angelina Angelova
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 48
Prognostic bioindicators in severe COVID-19 patients
Laura Bergantini, Elena Bargagli, Miriana d’Alessandro, et al.
Cytokine (2021) Vol. 141, pp. 155455-155455
Open Access | Times Cited: 40
Molecular dynamics simulation and docking analysis of NF-κB protein binding with sulindac acid
Shaban Ahmad, Piyush Bhanu, Jitendra Kumar, et al.
Bioinformation (2022) Vol. 18, Iss. 3, pp. 170-179
Open Access | Times Cited: 35
Cytokine profiles in the detection of severe lung involvement in hospitalized patients with COVID-19: The IL-8/IL-32 axis
Laura Bergantini, Miriana d’Alessandro, Paolo Cameli, et al.
Cytokine (2022) Vol. 151, pp. 155804-155804
Open Access | Times Cited: 28
Brain diffusion alterations in patients with COVID-19 pathology and neurological manifestations
Anna Caroli, Serena Capelli, Angela Napolitano, et al.
NeuroImage Clinical (2023) Vol. 37, pp. 103338-103338
Open Access | Times Cited: 20
Immunomodulatory approaches in managing lung inflammation in COVID‐19: A double‐edge sword
Geetika Verma, Manish Dhawan, AbdulRahman A. Saied, et al.
Immunity Inflammation and Disease (2023) Vol. 11, Iss. 9
Open Access | Times Cited: 18
COVID-19: Lessons Learned from Molecular and Clinical Research
Manuela Rizzi, Pier Paolo Sainaghi
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 2, pp. 616-616
Open Access
Janus kinase (JAK)-inhibitors and coronavirus disease 2019 (Covid-19) outcomes: a systematic review and meta-analysis
Ronal Yosua Limen, Rudyanto Sedono, Adhrie Sugiarto, et al.
Expert Review of Anti-infective Therapy (2021) Vol. 20, Iss. 3, pp. 425-434
Open Access | Times Cited: 37
Characterization of SARS-CoV-2 ORF6 deletion variants detected in a nosocomial cluster during routine genomic surveillance, Lyon, France
Grégory Quéromès, Grégory Destras, Antonin Bal, et al.
Emerging Microbes & Infections (2021) Vol. 10, Iss. 1, pp. 167-177
Open Access | Times Cited: 35
Prognostic Markers in Hospitalized COVID-19 Patients: The Role of IP-10 and C-Reactive Protein
Manuela Rizzi, Martina Costanzo, Stelvio Tonello, et al.
Disease Markers (2022) Vol. 2022, pp. 1-14
Open Access | Times Cited: 25
Page 1 - Next Page

Scroll to top